期刊文献+

壳聚糖水凝胶的研制及其与C2C12细胞粘附、支持作用的实验研究 被引量:6

Development of Chitosan Hydrogel and the Effect of C2C12 Adhesion and Support
下载PDF
导出
摘要 研制可注射的壳聚糖水凝胶材料,并对该材料的理化特性进行检测,同时检验其是否能粘附并支持C2C12细胞生长。对不同温度下的壳聚糖溶液进行pH值的测定,并以壳聚糖溶液和β-甘油磷酸钠溶液为原料,制备温敏性壳聚糖水凝胶,对该材料的粘度及37℃成胶时间进行测定,显微镜下观察水凝胶材料的结构,通过C2C12细胞在其表面上的粘附与生长情况,判定该材料是否具有良好的细胞相容性。结果表明:该材料具有温度敏感性,即室温下为液态,37℃变为固态。当壳聚糖溶液浓度为2%时,加入45%β-甘油磷酸钠溶液后的成胶作用时间最短,约为15min。C2C12细胞在壳聚糖水凝胶材料上的粘附与生长情况良好。壳聚糖水凝胶可作为可注射性组织工程化心肌的支架材料,用于携带有效细胞进行缺血性心脏病的治疗。 To study the material of injectable chitosan hydrogel ,to assess its physico- chemical property and ability for C2C12 to adhere and grow. The temperature - responsive chitosan hydrogel was prepared with β - sodium glycerophosphate and chitosan of which the pH was determined under different temperature and the plastic viscosity and the time of solidification at 37℃ of the chitosan hydrogel were also assessed. Then, C2C12 were seeded on the surface of the material and observed under microscope to determine whether the material had a good cytocompatibility. Results showed that the temperature - responsive chitosan hydrogel was prepared successfully, it was liquid at room temperature while it became solid hydrogel at 37 ℃. The plastic viscosity raised with the time and the solidification time was the shortest (within 15 min) when the chitosan hydrogel was prepared with 45% β- sodium glycerophosphate and 2% chitosan. C2C12 adhered and grew well on the chitosan hydrogel material. Our study proves that temperature - responsive chitosan hydrogel can be used as an injectable scaffolds carrying effective cells for heart disease treatment .
出处 《生物医学工程研究》 2008年第2期121-124,共4页 Journal Of Biomedical Engineering Research
基金 "十一五"863生物技术领域重大项目课题(2006AA02A105) 国家自然科学基金资助项目(30530220) 北京市自然科学基金资助项目(7062053)
关键词 壳聚糖水凝胶 温敏性 C2C12细胞 可注射性 支架材料 Chitosan hydrogel Temperature - responsive C2C 12 Injectable Scaffold
  • 相关文献

参考文献11

  • 1[1]Christman KL,Fok HH,Sievers RE,et al.Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction[J].Tissue Eng,2004,10(3/4):403-409.
  • 2[2]Christman KL,Vardanian AJ,Fang Q,et al.Injectable fibrin scaffold improves cell transplant survival,reduces infarct expansion,and induces neovasculature formation in ischemic myocardium[J].J Am Coll Cardiol,2004,44:654-660.
  • 3[3]Okamoto Y,Minami S,Matsuhashi A,et al.Application of polymeric N-acetyl-d-glucosamine (chitin) to veterinary practice[J].J Vet Med Sci,1993,55:743-752
  • 4[4]Chenite A,Chaput C,Wang D,et al.Novel injectable neutral solutions of chitosan form biodegradable gels in situ[J].Biomaterials,2000,21:2155–2161.
  • 5[5]Yoon Yeo,Wenliang Geng,Taichi Ito,et al.Photocrosslinkable hydrogel for myocyte cell culture and injection.Journal of biomedical matericals research[J].part B,Applied biomaterials,2007,81(2):312-322.
  • 6[6]Dorfman J,Duong M,Zibaitis A,et al.Myocardial tissue engineering with autologous myoblast implantation[J].J Thorac Cardiovasc Surg,1998,116:744-751.
  • 7[7]Muller-Ehmsen J,Whittaker P,Kloner RA,et al.Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium[J].J Mol Cell Cardiol,2002,34:107-116.
  • 8[8]Muller-Ehmsen J,Peterson KL,Kedes L,et al.Rebuilding a damaged heart:Long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function[J].Circulation,2002,105:1720-1726.
  • 9[9]Reinecke H,Zhang M,Bartosek T,et al.Survival,integration,and differentiation of cardiomyocyte grafts:a study in normal and injured rat hearts[J].Circulation,1999,100:193-202.
  • 10[10]Klug MG,Soonpaa MH,Koh GY,et al.Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts[J].J Clin Invest,1996,98:216-224.

同被引文献75

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部